Health
Patients with Relapsed/Refractory AML may Benefit from Treatment with Ficlatuzumab + Chemotherapy – OncoZine
Ficlatuzumab (AV-299) in combination with cytarabine (ara-C), demonstrates signs of clinical efficacy in patients with r/r AML….
Ficlatuzumab (formerly known as AV-299), a potent hepatocyte growth factor (HGF) immunoglobulin G1 (IgG1) inhibitory antibody that binds to the HGF ligand with high affinity and specificity, in combination with cytarabine (also known as arabinofuranosyl…
Continue Reading
-
Noosa News20 hours agoHow Lily Steele-Park took her rapist to court and won
-
Noosa News24 hours agoStar’s Brisbane casino has been in the headlines for months: What’s the latest?
-
Business23 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025
-
Noosa News21 hours agoE-biker charged with riding dangerously, assaulting cop